XML 131 R114.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation - NSOs (Details) - NSOs - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 28, 2014
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]        
Outstanding, shares 2,847 [1] 2,396 [1] 1,375 [1] 975
Outstanding, Weighted Average Exercise Price $ 39.00 [1] $ 45.82 [1] $ 60.62 [1] $ 70.90
Outstanding, Weighted Average Fair Value $ 15.49 [1] $ 19.15 [1] $ 30.47 [1] $ 37.15
Outstanding, Weighted Average Remaining Contractual Term (in years) 6 years 6 months 26 days [1] 8 years 2 months 12 days [1] 8 years 3 months 15 days [1] 9 years
Outstanding, Aggregate Intrinsic Value $ 21,897 [1] $ 6,163 [1] $ 0 [1] $ 1,164
Grants in period, shares 932 1,363 449  
Grants in period, Weighted Average Exercise Price $ 32.12 $ 30.43 $ 57.91  
Grants in period, Weighted Average Fair Value $ 7.97 $ 7.46 $ 25.81  
Exercised in period, shares (400)   (3)  
Exercised in period, Weighted Average Exercise Price $ 28.31   $ 49.40  
Exercised in period, Weighted Average Fair Value $ 8.54   $ 23.86  
Cancelled in period, shares (87) (67) (31)  
Cancelled in period, Weighted Average Exercise Price $ 48.48 $ 60.45 $ 64.01  
Cancelled in Period, Weighted Average Fair Value $ 23.91 $ 30.55 $ 33.63  
Forfeitures in period, shares (447) (275) (160)  
Forfeitures in period, Weighted Average Exercise Price $ 29.24 $ 39.89 $ 60.20  
Forfeitures in period, Weighted Average Fair Value $ 8.31 $ 15.04 $ 29.88  
Adjustment due to Special Cash Dividend, shares 453   145  
Vested and exercisable, shares [1] 1,187      
Vested and exercisable, Weighted Average Exercise Price [1] $ 48.48      
Vested and exercisable, Weighted Average Fair Value [1] $ 23.96      
Vested and exercisable, Weighted Average Remaining Contractual Term (in years) [1] 3 years 11 months 23 days      
Vested and exercisable, Aggregate Intrinsic Value [1] $ 3,235      
[1] (1)The weighted average exercise price and weighted-average fair value of options outstanding as of the end of each reporting period reflect the adjustments to the awards as a result of the respective special cash dividend.